ArticleInternational journal of nanomedicine2026

Astragaloside IV Co-Loaded Osimertinib Liposomes Alleviate EGFR-TKI Resistance in Non-Small Cell Lung Cancer.

Mi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.